Related Experiment Video
Updated: Jul 11, 2026

Overexpressing and Purifying a Toxic Nuclease from Escherichia coli
Published on: August 29, 2025
Biochemical and genetic analyses of murine hepatitis virus Nsp15 endoribonuclease
Hyojeung Kang1, Kanchan Bhardwaj, Yi Li
1Department of Microbial and Molecular Pathogenesis, Texas A&M University System--HSC, TX 77843-2128, USA.
Abstract:
The goal of this project was to better define the relationship between the endoribonuclease activity of murine hepatitis virus (MHV) Nsp15 (mNsp15) and its role in virus infection. Molecular modeling demonstrated that the catalytic residues of mNsp15 are superimposable with its severe acute respiratory syndrome coronavirus ortholog. Alanine substitutions at three key residues in the mNsp15 catalytic pocket (H262, H277, and G275) and a double-mutant version (H262P and H277A) generated proteins with greatly reduced but detectable endoribonuclease activities. Furthermore, these mutant proteins demonstrated lower cleavage specificities for uridylate than wild-type (WT) mNsp15. These mutations were successfully incorporated into viruses named vH262A, vH277A, vG275A, and vH262P+H277A. All four mutant viruses formed plaques with diameters similar to that of MHV-A59 1000 (WT virus) on several different cell lines. Interestingly, viruses with a mutation at a noncatalytic residue, D324A, could not be recovered despite repeated attempts, and expression of mNsp15 containing the D324A mutation in Escherichia coli resulted in an insoluble protein. Plaques derived from vH262A produced approximately 6- to 13-fold fewer PFU than those from WT virus. Cells infected with mNsp15 mutant viruses accumulated lesser amounts of plus- and minus-sense subgenomic RNAs and spike protein than WT virus. The expression of mNsp15 in trans by transient transfection partially restored RNA synthesis by vH262A. These results demonstrate that mNsp15 is required for optimal infection by MHV.
Insights
Murine hepatitis virus (MHV) Nsp15 (mNsp15) endoribonuclease activity is crucial for optimal viral infection. Mutations reducing mNsp15 activity impair viral RNA replication and protein synthesis.
Area of Science:
- Virology
- Molecular Biology
- Enzymology
Background:
- Murine hepatitis virus (MHV) is a significant pathogen.
- The Nsp15 endoribonuclease (mNsp15) is essential for viral replication.
- Understanding mNsp15's enzymatic activity is key to controlling MHV infection.
Purpose of the Study:
- To investigate the relationship between mNsp15 endoribonuclease activity and MHV infection.
- To characterize the impact of mutations in the mNsp15 catalytic pocket on its function.
- To assess the role of mNsp15 in viral RNA synthesis and replication.
Main Methods:
- Molecular modeling to compare mNsp15 with SARS-CoV orthologs.
- Site-directed mutagenesis to alter key residues in the mNsp15 catalytic pocket (H262, H277, G275).
- Generation and characterization of mutant MHV viruses (vH262A, vH277A, vG275A, vH262P+H277A).
- Plaque assays, plaque-forming unit (PFU) enumeration, and analysis of viral RNA and protein levels.
- In trans expression experiments to assess rescue of viral RNA synthesis.
Main Results:
- Mutations in the mNsp15 catalytic pocket reduced endoribonuclease activity and uridylate cleavage specificity.
- Mutant viruses with catalytic site mutations (vH262A, vH277A, vG275A, vH262P+H277A) were viable but showed reduced PFU and viral RNA/protein accumulation.
- A mutation at a non-catalytic residue (D324A) resulted in an insoluble protein and inability to recover the virus.
- In trans expression of wild-type mNsp15 partially restored RNA synthesis in a mutant virus.
Conclusions:
- mNsp15's endoribonuclease activity is essential for optimal MHV replication.
- Specific catalytic residues and their enzymatic function are critical for viral propagation.
- mNsp15 plays a vital role in the synthesis of viral subgenomic RNAs and spike protein.
- Targeting mNsp15 activity represents a potential strategy for antiviral development against MHV.
Related Concept Videos
Leaky Scanning
Inhibitors Of Virion Release
Hepatitis

